Silicon Investor - IDPH--Positive preliminary results for pivotal trial of IDCopyright © 2026 Knight Sac Media. All rights reserved.https://www.siliconinvestor.com/subject.aspx?subjectid=5704 IDEC Pharmaceuticals annouced over PRNewswire on May 21 positive results from a Phase III pivotal trial of IDEC-C2B8 as a single-agent treatment for patients with relapsed low-grade or follicular non-Hodgkin's lymphoma cancer. Anybody following this company? I am looking for discussion on this company and its future potential.https://www.siliconinvestor.com/images/Logo380x132.pngSI - IDPH--Positive preliminary results for pivotal trial of IDhttps://www.siliconinvestor.com/subject.aspx?subjectid=570438013210